2011
DOI: 10.1586/edm.10.73
|View full text |Cite
|
Sign up to set email alerts
|

Skin substitutes for burn wound healing: current and future approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 104 publications
(131 reference statements)
0
9
0
1
Order By: Relevance
“…Full- or split-thickness skin grafting is the current gold standard for wound closure following severe burn wound injury. A few synthetic substitutes have made their ways to the market, but most provide only a temporary barrier until autografts are available for permanent closure ( Supp, 2011 ). To the best of our knowledge, there is no synthetic product currently indicated for treating third-degree burns.…”
Section: Discussionmentioning
confidence: 99%
“…Full- or split-thickness skin grafting is the current gold standard for wound closure following severe burn wound injury. A few synthetic substitutes have made their ways to the market, but most provide only a temporary barrier until autografts are available for permanent closure ( Supp, 2011 ). To the best of our knowledge, there is no synthetic product currently indicated for treating third-degree burns.…”
Section: Discussionmentioning
confidence: 99%
“…Apligraf is an only commercially available composite bi-layer product which is approved by FDA for the treatment of chronic venous ulcers (Veves et al 2001 ; Zaulyanov and Kirsner 2007 ). Patients, treatment with apligraf, experienced faster healing and decreased the complication rate, by this it meant less need for medical follow up (Límová 2010 ; Supp 2011 ). Apligraf accelerates healing in diabetic neuropathic ulcers as compared with standard therapy of moist gauze and offloading (Supp 2011 ).…”
Section: Skin Substitutes Containing Allogenic Live Fibroblastsmentioning
confidence: 99%
“…Nonetheless, while advances in clinical management and therapeutic modalities have been achieved, serious limitations in the improvement of wound healing remain, largely due to the complexity of the underlying biology [1-3]. It is widely recognized that a significant improvement in outcomes will come as a result of biologically active therapies for wound healing [4]. A variety of efforts are underway to develop bioengineered skin substitutes to function as “artificial skin.” Unfortunately, because they involve the use of grafted cells, most of these approaches are expensive, labor intensive, present numerous medical and regulatory issues, and results of clinical studies are inconsistent with respect to the efficacy of specific products [5].…”
Section: Introductionmentioning
confidence: 99%